Skip to main content
. 2017 Aug 16;26(10):1266–1276. doi: 10.1002/pds.4286

Table 1.

Sociodemographic, lifestyle, and health characteristics of the sample by antidepressant use status during pregnancy before gestational week 34 (n = 5887)

Depression, Nonmedicated Depression, SSRI Monotherapy Depression, SNRI Monotherapy Depression, TCA Monotherapy Depression, OAD Monotherapy
n = 5106 n = 654 n = 75 n = 21 n = 31
Maternal age, y; mean ± SD 29.6 ± 5.1 30.0 ± 5.0 29.2 ± 5.6 31.0 ± 5.5 30.9 ± 4.3
Multiple gestation; no., %
No 5030 (98.5) 637 (97.4) 73 (97.3) 21 (100.0) 30 (96.8)
Yes 76 (1.5) 17 (2.6) 2 (2.7) 1 (3.2)
Gestational age at delivery, wk; mean ± SD 39.4 ± 1.70 39.1 ± 1.81 39.2 ± 1.98 38.6 ± 1.53 39.1 ± 1.88
Parity; no., %
0 2410 (47.2) 357 (54.6) 38 (50.7) 10 (47.6) 12 (38.7)
≥1 2696 (52.8) 297 (45.4) 37 (49.3) 11 (52.4) 19 (61.3)
Marital status; no., %
Married/cohabiting 4663 (91.3) 566 (86.5) 62 (82.7) 20 (95.2) 28 (90.3)
Other 399 (7.8) 84 (12.8) 11 (14.7) 1 (4.8) 3 (9.7)
Educational level; no., %
University/college 2428 (47.6) 311 (47.6) 29 (38.7) 7 (33.3) 15 (48.4)
Lower than university/college 2326 (45.6) 301 (46.0) 43 (57.3) 14 (66.7) 16 (51.6)
Woman's gross yearly income, NOK; no., %
No income 204 (4.0) 29 (4.4) 1 (1.3) 1 (4.8) 1 (3.2)
<199 999 1858 (36.4) 277 (42.4) 31 (41.3) 9 (42.9) 16 (51.6)
200‐399 999 2470 (48.4) 286 (43.7) 33 (44.0) 10 (47.6) 11 (35.5)
>400 000 402 (7.9) 43 (6.6) 7 (9.3) 1 (4.8) 1 (3.2)
BMI at conception; mean ± SD 24.3 ± 4.6 24.5 ± 4.9 24.5 ± 5.0 25.6 ± 4.5 22.6 ± 3.7
Weight gain, kg, until GW 30; mean ± SD 9.8 ± 5.4 9.5 ± 5.4 10.9 ± 6.0 10.0 ± 4.8 9.7 ± 6.6
Smoking status at GW 30; no., %
No 3643 (71.4) 439 (67.1) 42 (56.0) 15 (71.4) 13 (41.9)
Yes 728 (14.3) 111 (17.0) 22 (29.3) 3 (14.3) 10 (32.3)
Stopped in pregnancy 683 (13.4) 100 (15.3) 9 (12.0) 3 (14.3) 8 (25.8)
Infertility treatment; no., %
No 4831 (94.6) 623 (95.3) 72 (96.0) 20 (95.2) 28 (90.3)
Yes 275 (5.4) 31 (4.7) 3 (4.0) 1 (4.8) 3 (9.7)
Chronic hypertension and use of antihypertensive before conception; no., %
No 5098 (99.8) 653 (99.9) 75 (100.0) 21 (100.0) 31 (100.0)
Yes 8 (0.2) 1 (0.1)
Systolic blood pressure, mm Hga; mean ± SD 113.1 ± 12.5 111.7 ± 13.1 107.7 ± 9.8 114.8 ± 14.4 110.0 ± 15.0
Diastolic blood pressure, mm Hga; mean ± SD 68.1 ± 9.6 67.3 ± 9.7 66.0 ± 8.2 69.4 ± 9.0 66.8 ± 9.7
Preexisting diabetes; no., %
No 5181 (99.4) 650 (99.4) 75 (100.0) 21 (100.0) 31 (100.0)
Yes 34 (0.7) 4 (0.6)
Preeclampsia history; no., %
No 4910 (96.2) 627 (95.9) 71 (94.7) 21 (100.0) 29 (93.6)
Yes 196 (3.8) 27 (4.1) 4 (5.3) 2 (6.5)
History of spontaneous abortion(s)b; no., %
No 3480 (68.2) 466 (71.3) 53 (70.7) 13 (61.9) 18 (58.1)
Yes 1000 (19.6) 121 (18.5) 12 (16.0) 6 (28.6) 12 (38.7)
Lifetime major depressionc; no., %
No 1328 (26.0) 46 (7.0) 7 (9.3) 2 (9.5) 2 (6.4)
Yes 3491 (68.4) 582 (89.0) 66 (88.0) 19 (90.5) 29 (93.6)
Depressive symptoms at GW 17; z‐score ± SD −0.03 ± 0.98 0.18 ± 1.11 0.37 ± 1.15 0.14 ± 0.87 0.39 ± 1.08
Depressive symptoms at GW 30; z‐score ± SD −0.02 ± 0.97 0.10 ± 1.13 0.43 ± 1.39 0.31 ± 1.08 0.44 ± 1.31
Comedication use in pregnancy; no., %
Other psychotropic drugsd 142 (2.8) 81 (12.4) 10 (13.3) 5 (23.8) 8 (25.8)
NSAIDs and/or opioid analgesics 450 (8.8) 85 (13.0) 11 (14.7) 3 (14.3) 6 (19.4)

Abbreviations: BMI, body mass index; GW, gestational week; NOK, Norwegian Krone (1 NOK=0.13 USD); NSAID, nonsteroidal anti‐inflammatory drugs; OADs, other antidepressants; SNRIs, serotonin‐norepinephrine reuptake inhibitors; SSRIs, selective serotonin reuptake inhibitors; TCA, tricyclic antidepressants.

Numbers may not add up to total due to missing values, ranging from 1% to 3% for smoking, BMI, and socioeconomic status, to 5% to 7% for educational level, lifetime history of major depression and depressive, and anxiety symptoms in GW 17, 8% to 10% for depressive and anxiety symptoms in GW 30 and weight gain, and 14% for baseline blood pressure values.

a

Self‐reported systolic and diastolic blood pressure as measured at first antenatal visit.

b

Defined as history of spontaneous abortion(s) before GW 12.

c

Defined as Kendlers lifetime major depression scale score of 3 or more of 6 depressive symptoms of duration of more than 2 weeks.

d

Other psychotropic drugs include all medications under the Anatomical Therapeutic Chemical code N05, ie, antipsychotics, anxiolytics, hypnotics, and sedatives.